Ignet
Search (e.g., vaccine, IFNG): Help
About
Home
Introduction
Statistics
Programs
Dignet
Gene
GenePair
BioSummarAI
Help & Docs
Documents
Help
FAQs
Links
Acknowledge
Disclaimer
Contact Us
UM Logo

UMMS Logo

UMMS Logo

Gene Information

Gene symbol: ASPH

Gene name: aspartate beta-hydroxylase

HGNC ID: 757

Synonyms: CASQ2BP1, BAH, JCTN, HAAH

Related Genes

# Gene Symbol Number of hits
1 CD4 1 hits
2 CD8A 1 hits
3 HLA-A 1 hits

Related Sentences

# PMID Sentence
1 25629522 The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
2 25629522 Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
3 25629522 Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
4 25629522 ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
5 25629522 Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
6 25629522 Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
7 25629522 The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
8 25629522 Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
9 25629522 Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
10 25629522 ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
11 25629522 Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
12 25629522 Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
13 25629522 The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
14 25629522 Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
15 25629522 Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
16 25629522 ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
17 25629522 Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
18 25629522 Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
19 25629522 The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
20 25629522 Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
21 25629522 Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
22 25629522 ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
23 25629522 Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
24 25629522 Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
25 25629522 The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
26 25629522 Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
27 25629522 Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
28 25629522 ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
29 25629522 Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
30 25629522 Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.